HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,455 | -23.0% | 58,695 | -13.3% | 0.00% | – |
| Q2 2023 | $78,525 | -3.8% | 67,694 | +25.2% | 0.00% | – |
| Q1 2023 | $81,649 | -62.8% | 54,072 | -38.4% | 0.00% | – |
| Q4 2022 | $219,446 | -38.0% | 87,778 | +4.9% | 0.00% | – |
| Q3 2022 | $354,000 | +57.3% | 83,654 | +4.0% | 0.00% | – |
| Q2 2022 | $225,000 | -45.4% | 80,440 | +11.8% | 0.00% | – |
| Q1 2022 | $412,000 | -27.8% | 71,933 | +15.0% | 0.00% | – |
| Q4 2021 | $571,000 | -17.5% | 62,562 | -3.4% | 0.00% | – |
| Q3 2021 | $692,000 | -97.4% | 64,757 | -96.2% | 0.00% | -100.0% |
| Q2 2021 | $26,606,000 | -4.4% | 1,714,290 | -0.2% | 0.01% | 0.0% |
| Q1 2021 | $27,843,000 | -23.7% | 1,717,637 | -0.4% | 0.01% | -36.4% |
| Q4 2020 | $36,486,000 | +41.7% | 1,723,864 | -0.8% | 0.01% | +22.2% |
| Q3 2020 | $25,755,000 | -1.7% | 1,737,861 | -2.4% | 0.01% | 0.0% |
| Q2 2020 | $26,192,000 | +686.8% | 1,780,638 | +528.1% | 0.01% | +800.0% |
| Q1 2020 | $3,329,000 | -46.0% | 283,494 | +8.1% | 0.00% | -50.0% |
| Q4 2019 | $6,161,000 | +15.4% | 262,157 | -9.2% | 0.00% | +100.0% |
| Q3 2019 | $5,340,000 | -0.5% | 288,675 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $5,366,000 | -23.9% | 288,675 | +0.0% | 0.00% | -50.0% |
| Q1 2019 | $7,054,000 | -5.9% | 288,671 | -0.1% | 0.00% | -33.3% |
| Q4 2018 | $7,493,000 | -18.4% | 288,885 | -0.4% | 0.00% | 0.0% |
| Q3 2018 | $9,182,000 | -47.6% | 290,094 | -35.6% | 0.00% | -50.0% |
| Q2 2018 | $17,510,000 | +40.0% | 450,691 | -0.5% | 0.01% | +20.0% |
| Q1 2018 | $12,506,000 | +20.1% | 453,118 | -21.2% | 0.01% | +25.0% |
| Q4 2017 | $10,412,000 | +12.1% | 575,265 | +0.0% | 0.00% | +33.3% |
| Q3 2017 | $9,290,000 | +16.6% | 575,241 | -0.0% | 0.00% | +50.0% |
| Q2 2017 | $7,968,000 | -81.6% | 575,312 | -80.1% | 0.00% | -85.7% |
| Q1 2017 | $43,379,000 | +465.3% | 2,891,917 | +393.7% | 0.01% | +366.7% |
| Q4 2016 | $7,674,000 | -83.9% | 585,819 | -78.9% | 0.00% | -81.2% |
| Q3 2016 | $47,790,000 | -9.0% | 2,773,656 | -4.7% | 0.02% | -15.8% |
| Q2 2016 | $52,519,000 | -12.1% | 2,909,591 | -7.5% | 0.02% | -20.8% |
| Q1 2016 | $59,746,000 | -32.4% | 3,146,208 | -5.0% | 0.02% | -31.4% |
| Q4 2015 | $88,441,000 | +12.0% | 3,312,385 | +2.4% | 0.04% | +6.1% |
| Q3 2015 | $78,944,000 | +162.0% | 3,235,414 | +234.6% | 0.03% | +175.0% |
| Q2 2015 | $30,131,000 | – | 966,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |